Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for SCN8A developmental and epileptic encephalopathy
ACTRN12625000845437Phase 3Not yet recruiting
- Sponsor
- University of Melbourne
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of riluzole, sponsored by University of Melbourne. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
riluzole
Beyond the preview
Go deeper on ACTRN12625000845437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000845437.